PATENT CLAIM ANALYSIS

Application Number: 16287559
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "204100"]

Abstract:
The present invention relates to novel CD4+ and CD8+ T cell epitopes that are specific for HPV-specific E6 and E7 oncoproteins, to peptides comprising these novel T cell epitopes, and to (vaccine) compositions comprising these peptides for use in methods for the prevention and/or treatment of HPV related diseases. Preferred epitopes are recognized by a T cell that infiltrates a cervical neoplastic lesion or by a T cell from a draining lymph node, and are presented by an HLA-DQ or HLA-DP molecule, or an HLA-B.

Claim (Index 6):
The immunogenic pharmaceutical composition according to  claim 1 , wherein the pharmaceutically acceptable adjuvant acts via a Toll-like receptor.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 99.0
- Lexical Diversity: 1.57627
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15678970', '14453286', '12451983', '12592815', '11343606']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8469148802373785
- 35 USC 102 Novelty (BERT): 0.5944293535617605
- Combined Prediction Score: 0.8216663275698167
- Mean Citation Score: 565.023204
- Max Citation Score: 698.5127
- Similarity Product: 413.94977569962737

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test